Aier Eye Hospital group allocates idle funds to wealth management products

Aier Eye Hospital Group Co., Ltd. announced the implementation of cash management using idle self-owned funds, following approval from its Sixth Board of Directors and Sixth Board of Supervisors on March 24, 2025. The company will utilize up to 1.5 bn yuan of idle funds to purchase highly secure, liquid, and low-risk wealth management products for a period of 12 months, with funds capable of revolving use.

Specifically, Aier Eye Hospital International (Hong Kong) Co., Limited, a wholly-owned subsidiary, has invested in two wealth management products. The first is Ningyin Wealth Management's Ningxin Daily Fixed Income Class Daily Wealth Management 55, G-share, with a subscription of 100m yuan. The second is CITIC Securities Investment's Xingye Anxiang A-Share No. 2 Collective Asset Management Plan, also with a subscription of 100m yuan. Both products are denominated in yuan, classified as low-to-medium risk, and sourced from the company's own funds.

These initiatives are designed to improve capital utilization efficiency and generate investment returns for the company and its shareholders, while ensuring the security of funds and not impacting daily operations. The company has established stringent risk control measures, including adherence to prudent investment principles, continuous monitoring of product performance, and internal audits.